UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 327

Sortiert nach

Cancer biomarkers

Molecular oncology, 2012-04, Vol.6 (2), p.140-146

2012

Link zum Volltext

Verfügbarkeit prüfen

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

Journal of clinical oncology, 2013-03, Vol.31 (7), p.961-965

2013

Link zum Volltext

Verfügbarkeit prüfen

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Journal of clinical oncology, 2016-02, Vol.34 (6), p.611-635

2016

Link zum Volltext

Verfügbarkeit prüfen

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

Journal of clinical oncology, 2012-03, Vol.30 (9), p.936-942

2012

Link zum Volltext

Verfügbarkeit prüfen

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

CA: a cancer journal for clinicians, 2016-01, Vol.66 (1), p.43-73

2016

Link zum Volltext

Verfügbarkeit prüfen

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

Molecular cell, 2012-08, Vol.47 (4), p.570-584

2012

Link zum Volltext

Verfügbarkeit prüfen

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

Journal of clinical oncology, 2020-12, Vol.38 (35), p.4184-4193

2020

Link zum Volltext

Verfügbarkeit prüfen

Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?

JNCI : Journal of the National Cancer Institute, 2019-04, Vol.111 (4), p.339-341

2019

Link zum Volltext

Verfügbarkeit prüfen

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes

Clinical biochemistry, 2016-12, Vol.49 (18), p.1354-1360

2016

Link zum Volltext

Verfügbarkeit prüfen

Management of Aromatase Inhibitor-Induced Musculoskeletal Symptoms

JCO oncology practice, 2020-11, Vol.16 (11), p.733-739

2020

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Clinical cancer research, 2018-08, Vol.24 (15), p.3602-3610

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

Cancer, 2014-08, Vol.120 (16), p.2403-2411

2014

Link zum Volltext

Verfügbarkeit prüfen

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer

Clinical cancer research, 2015-06, Vol.21 (11), p.2487-2498

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Journal of clinical oncology, 2018-02, Vol.36 (4), p.326-332

2018

Link zum Volltext

Verfügbarkeit prüfen

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations

Journal of clinical oncology, 2016-07, Vol.34 (19), p.2303-2311

2016

Link zum Volltext

Verfügbarkeit prüfen

Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study

Cancer epidemiology, biomarkers & prevention, 2023-10, Vol.32 (10), p.1302

2023

Link zum Volltext

Verfügbarkeit prüfen

Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study

Supportive care in cancer, 2020-09, Vol.28 (9), p.4163-4172

2020

Link zum Volltext

Verfügbarkeit prüfen

Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer

Breast cancer research and treatment, 2021-05, Vol.187 (1), p.287-294

2021

Link zum Volltext

Verfügbarkeit prüfen

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol

Technology in cancer research & treatment, 2022, Vol.21, p.15330338221127169

2022

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability

Cancer chemotherapy and pharmacology, 2021-09, Vol.88 (3), p.475-483

2021

Link zum Volltext

Verfügbarkeit prüfen

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy

Breast cancer research and treatment, 2018-10, Vol.171 (3), p.657-666

2018

Link zum Volltext

Verfügbarkeit prüfen

Promoting quality and evidence-based care in early-stage breast cancer follow-up

JNCI : Journal of the National Cancer Institute, 2014-04, Vol.106 (4), p.dju034-dju034

2014

Link zum Volltext

Verfügbarkeit prüfen

Tumor marker usage and medical care costs among older early-stage breast cancer survivors

Journal of clinical oncology, 2015-01, Vol.33 (2), p.149-155

2015

Link zum Volltext

Verfügbarkeit prüfen

Integrative Oncology Education: An Emerging Competency for Oncology Providers

Current oncology (Toronto), 2021-02, Vol.28 (1), p.853-862

2021

Link zum Volltext

Verfügbarkeit prüfen

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

BMC medical research methodology, 2021-11, Vol.21 (1), p.1-244, Article 244

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 327

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(307)
Mit Volltextzugriff
(288)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Cancer biomarkers

Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Predictors of Aromatase Inhibitor Discontinuation as a Result of Treatment-Emergent Symptoms in Early-Stage Breast Cancer

American Cancer Society/American Society of Clinical Oncology Breast Cancer Survivorship Care Guideline

Activation of an IL6 Inflammatory Loop Mediates Trastuzumab Resistance in HER2+ Breast Cancer by Expanding the Cancer Stem Cell Population

Survival, Pathologic Response, and Genomics in CALGB 40601 (Alliance), a Neoadjuvant Phase III Trial of Paclitaxel-Trastuzumab With or Without Lapatinib in HER2-Positive Breast Cancer

Surveillance After Treatment of Localized Breast Cancer: Time for Reappraisal?

Comparative analysis of circulating tumor DNA stability In K3EDTA, Streck, and CellSave blood collection tubes

Management of Aromatase Inhibitor-Induced Musculoskeletal Symptoms

Paclitaxel Plasma Concentration after the First Infusion Predicts Treatment-Limiting Peripheral Neuropathy

Patient‐reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy

Development of circulating tumor cell-endocrine therapy index in patients with hormone receptor-positive breast cancer

Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor-Associated Arthralgias in Early-Stage Breast Cancer: SWOG S1202

Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations

Adverse Health Outcomes among Rural and Urban Breast Cancer Survivors: A Population-Based Cohort Study

Reporting of paclitaxel-induced peripheral neuropathy symptoms to clinicians among women with breast cancer: a qualitative study

Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol

Feasibility of pharmacometabolomics to identify potential predictors of paclitaxel pharmacokinetic variability

Pharmacometabolomics reveals a role for histidine, phenylalanine, and threonine in the development of paclitaxel-induced peripheral neuropathy

Promoting quality and evidence-based care in early-stage breast cancer follow-up

Tumor marker usage and medical care costs among older early-stage breast cancer survivors

Integrative Oncology Education: An Emerging Competency for Oncology Providers

Visualizing adverse events in clinical trials using correspondence analysis with R-package visae

Suchergebnisse filtern